The Framingham Steatosis Index (FSI) is a noninvasive scoring system that estimates hepatic fat content using routinely collected clinical and biochemical parameters, including age, sex, body mass index (BMI), triglyceride levels, presence of hypertension and diabetes, and the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) ratio [6]. This evidence concerns the gene GPT and steatosis.